JPH044312B2 - - Google Patents

Info

Publication number
JPH044312B2
JPH044312B2 JP57103544A JP10354482A JPH044312B2 JP H044312 B2 JPH044312 B2 JP H044312B2 JP 57103544 A JP57103544 A JP 57103544A JP 10354482 A JP10354482 A JP 10354482A JP H044312 B2 JPH044312 B2 JP H044312B2
Authority
JP
Japan
Prior art keywords
methyl
yield
acid
water
melting point
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP57103544A
Other languages
English (en)
Japanese (ja)
Other versions
JPS58219169A (ja
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to JP57103544A priority Critical patent/JPS58219169A/ja
Priority to US06/501,012 priority patent/US4602027A/en
Priority to CA000429900A priority patent/CA1195986A/en
Priority to FI832036A priority patent/FI832036L/fi
Priority to AU15657/83A priority patent/AU1565783A/en
Priority to ES523152A priority patent/ES8503676A1/es
Priority to ZA834307A priority patent/ZA834307B/xx
Priority to GR71647A priority patent/GR78290B/el
Priority to PT76871A priority patent/PT76871B/pt
Priority to NO832146A priority patent/NO832146L/no
Priority to DK272083A priority patent/DK272083A/da
Priority to DE8383105829T priority patent/DE3374685D1/de
Priority to EP83105829A priority patent/EP0096890B1/en
Priority to HU832135A priority patent/HU189296B/hu
Priority to KR1019830002662A priority patent/KR840005116A/ko
Publication of JPS58219169A publication Critical patent/JPS58219169A/ja
Priority to ES538030A priority patent/ES8600751A1/es
Publication of JPH044312B2 publication Critical patent/JPH044312B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/32—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/36—One oxygen atom
    • C07D263/40—One oxygen atom attached in position 4

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
JP57103544A 1982-06-15 1982-06-15 オキサゾ−ル酢酸誘導体 Granted JPS58219169A (ja)

Priority Applications (16)

Application Number Priority Date Filing Date Title
JP57103544A JPS58219169A (ja) 1982-06-15 1982-06-15 オキサゾ−ル酢酸誘導体
US06/501,012 US4602027A (en) 1982-06-15 1983-06-06 Oxazoleacetic acid derivatives
CA000429900A CA1195986A (en) 1982-06-15 1983-06-07 Oxazoleacetic acid derivatives
FI832036A FI832036L (fi) 1982-06-15 1983-06-07 Foerfarande foer framstaellning av oxazolaettiksyra
AU15657/83A AU1565783A (en) 1982-06-15 1983-06-09 Oxazoleacetic acid derivatives
ES523152A ES8503676A1 (es) 1982-06-15 1983-06-10 Procedimiento de producir derivados de acido oxazolacetico
ZA834307A ZA834307B (en) 1982-06-15 1983-06-13 Oxazoleacetic acid derivatives
GR71647A GR78290B (en]) 1982-06-15 1983-06-13
NO832146A NO832146L (no) 1982-06-15 1983-06-14 Fremgangsmaate ved fremstilling av oxazoleddiksyrederivater
PT76871A PT76871B (en) 1982-06-15 1983-06-14 Oxazileacetic acid derivatives
DK272083A DK272083A (da) 1982-06-15 1983-06-14 Oxazoleddikesyrederivater
DE8383105829T DE3374685D1 (en) 1982-06-15 1983-06-14 Oxazoleacetic acid derivatives, process for their production and compositions containing said derivatives
EP83105829A EP0096890B1 (en) 1982-06-15 1983-06-14 Oxazoleacetic acid derivatives, process for their production and compositions containing said derivatives
HU832135A HU189296B (en) 1982-06-15 1983-06-15 Process for producing oxazole-4-acetic acid derivatives
KR1019830002662A KR840005116A (ko) 1982-06-15 1983-06-15 옥사졸초산 유도체의 제조방법
ES538030A ES8600751A1 (es) 1982-06-15 1984-11-16 Procedimiento de producir derivados de acido oxazolacetico.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP57103544A JPS58219169A (ja) 1982-06-15 1982-06-15 オキサゾ−ル酢酸誘導体

Publications (2)

Publication Number Publication Date
JPS58219169A JPS58219169A (ja) 1983-12-20
JPH044312B2 true JPH044312B2 (en]) 1992-01-27

Family

ID=14356777

Family Applications (1)

Application Number Title Priority Date Filing Date
JP57103544A Granted JPS58219169A (ja) 1982-06-15 1982-06-15 オキサゾ−ル酢酸誘導体

Country Status (15)

Country Link
US (1) US4602027A (en])
EP (1) EP0096890B1 (en])
JP (1) JPS58219169A (en])
KR (1) KR840005116A (en])
AU (1) AU1565783A (en])
CA (1) CA1195986A (en])
DE (1) DE3374685D1 (en])
DK (1) DK272083A (en])
ES (2) ES8503676A1 (en])
FI (1) FI832036L (en])
GR (1) GR78290B (en])
HU (1) HU189296B (en])
NO (1) NO832146L (en])
PT (1) PT76871B (en])
ZA (1) ZA834307B (en])

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8531608D0 (en) * 1985-12-23 1986-02-05 Beecham Group Plc Treatment
US5239080A (en) * 1989-02-08 1993-08-24 Takeda Chemical Industries, Ltd. Oxazole compounds and their use as antidiabetic and bone-reduction inhibitory agents
EP0409418A1 (en) * 1989-07-20 1991-01-23 Imperial Chemical Industries Plc Heterocyclic tertiary alcohols
EP0440183A1 (en) * 1990-02-01 1991-08-07 Takeda Chemical Industries, Ltd. Oxazole compounds, their production and use
DE69132944T2 (de) * 1990-11-30 2002-11-21 Otsuka Pharmaceutical Co., Ltd. Azolederivate als Inhibitor von Superoxide-Radikalen
CA2118706A1 (en) * 1992-07-13 1994-01-20 Saizo Shibata Novel thiazolidinedione compounds and use thereof
MY128323A (en) 1996-09-30 2007-01-31 Otsuka Pharma Co Ltd Thiazole derivatives for inhibition of cytokine production and of cell adhesion
ES2211053T3 (es) 1998-03-30 2004-07-01 Japan Tobacco Inc. Procedimiento para producir un compuesto de isooxazolidindiona.
AU780009B2 (en) * 1999-08-31 2005-02-24 Merck Sharp & Dohme Corp. Heterocyclic compounds and methods of use thereof
KR100459917B1 (ko) * 2001-12-14 2004-12-03 (주)바이오뉴트리젠 페놀릭산 유도체 및 이를 포함하는 혈중 지질 농도 관련질환의 예방 및 치료용 조성물

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3401120A (en) * 1965-10-23 1968-09-10 Gaf Corp Corrosion inhibitors
FI53314C (fi) * 1967-06-14 1978-04-10 Wyeth John & Brother Ltd Foerfarande foer framstaellning av farmaceutiskt anvaendbar 2-(fenyleller p-klorfenyl) oxazol-4-yl (aettiksyra -acetatsalt eller -acetamid)
GB1245087A (en) * 1967-10-26 1971-09-02 Wyeth John & Brother Ltd Heterocyclic compounds
US3578671A (en) * 1967-11-06 1971-05-11 Wyeth John & Brother Ltd Oxazoles
AR208400A1 (es) * 1974-03-13 1976-12-27 Yoshitomi Pharmaceutical Un metodo para producir nuevos acidos 5-alcoxi-4-oxazolalcanoicos 2-substituidos y sus esteres

Also Published As

Publication number Publication date
NO832146L (no) 1983-12-16
KR840005116A (ko) 1984-11-03
ES523152A0 (es) 1985-04-01
PT76871A (en) 1983-07-01
DK272083D0 (da) 1983-06-14
ZA834307B (en) 1984-03-28
ES8503676A1 (es) 1985-04-01
DE3374685D1 (en) 1988-01-07
PT76871B (en) 1986-01-27
FI832036A7 (fi) 1983-12-16
JPS58219169A (ja) 1983-12-20
EP0096890A2 (en) 1983-12-28
AU1565783A (en) 1983-12-22
EP0096890A3 (en) 1984-11-14
ES538030A0 (es) 1985-11-01
HU189296B (en) 1986-06-30
EP0096890B1 (en) 1987-11-25
CA1195986A (en) 1985-10-29
FI832036L (fi) 1983-12-16
FI832036A0 (fi) 1983-06-07
ES8600751A1 (es) 1985-11-01
DK272083A (da) 1983-12-16
US4602027A (en) 1986-07-22
GR78290B (en]) 1984-09-26

Similar Documents

Publication Publication Date Title
KR920002131B1 (ko) 타아졸리딘디온 유도체의 제조방법
AU2001282009B2 (en) Non-steroidal inflammation inhibitors
KR880002298B1 (ko) 술포네이트 유도체의 제조법
KR20070004769A (ko) 대사 장애의 치료에 사용되는 화합물, 약제학적 조성물 및그 사용방법
JP5474769B2 (ja) ペルオキシソーム増殖剤活性化受容体の活性化剤
WO2000075103A1 (fr) DERIVES D'ACIDE PHENYLPROPIONIQUE SUBSTITUES COMME AGONISTES DU RECEPTEUR HUMAIN ACTIVE DE LA PROLIFERATION DES PEROXYSOMES (PPAR) $g(a)
JP3419009B2 (ja) 縮合ベンゼンオキシ酢酸誘導体およびそれらを有効成分として含有する薬剤
RU2770061C2 (ru) Соединения дигидропиримидин-2-она и их медицинское применение
JPWO2006059744A1 (ja) ペルオキシソーム増殖剤活性化受容体δの活性化剤
JPH044312B2 (en])
FR2566404A1 (fr) Nouveaux derives de la 1,4-dihydropyridine, leurs sels, procede pour les preparer, et compositions pharmaceutiques les contenant
US4596816A (en) 4-aryl oxazoles
JPH021478A (ja) 二置換ピリジン類
CA2565184C (en) Butanoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic applications threreof
JPH0324073A (ja) ジベンゾ［１，５］ジオキソシン―５―オン誘導体類、薬物におけるそれらの使用およびそれらの調製方法
JPH0570633B2 (en])
JPH0119390B2 (en])
JPH0476989B2 (en])
JP2965610B2 (ja) 置換されたフエニル類
JP2765001B2 (ja) プロテアーゼ阻害剤
KR910000443B1 (ko) 할로알킬 티아졸의 제조방법 및 이 방법으로 제조한 할로알킬 티아졸
JPH08325250A (ja) 新規置換フェノール誘導体
JPH0393773A (ja) 置換アミノピリジン類
JPH01313460A (ja) Ｎ‐置換されたｎ‐アミノ‐ピロール
JPS6257635B2 (en])